Experimental infection of C3H/HeJ mice with the NY18 isolate of Anaplasma phagocytophilum

被引:17
作者
Blas-Machado, U. [1 ]
de la Fuente, J.
Blouin, E. F.
Almazan, C.
Kocan, K. M.
Mysore, J. V.
机构
[1] Univ Georgia, Coll Vet Med, Athens Vet Diagnost Lab, Athens, GA 30602 USA
[2] Univ Georgia, Coll Vet Med, Dept Vet Pathol, Athens, GA 30602 USA
[3] Oklahoma State Univ, Dept Vet Pathobiol, Stillwater, OK 74078 USA
[4] Oklahoma State Univ, Ctr Vet Hlth Sci, Stillwater, OK 74078 USA
[5] Inst Invest Recursos Cinegetcos IREC, Ciudad Real, Spain
基金
美国国家卫生研究院;
关键词
Anaplasma phagocytophilum; animal model; C3H/HeJ mice; human granulocytic anaplasmosis; human granulocytic ehrlichiosis;
D O I
10.1354/vp.44-1-64
中图分类号
R36 [病理学];
学科分类号
100104 [病理学与病理生理学];
摘要
Human granulocytic anaplasmosis (HGA), an emerging disease of public health concern in many areas of the world, is caused by Anaplasma phagocytophilum. Small animal models of A phagocytophilum in laboratory mice have been developed and used to study the pathogenesis of HGA. In this study, we characterized the pathologic changes in acute infection of C3H/HeJ mice experimentally infected with the NY18 isolate of A phagocytophilum. Although no clinical signs were noted, acute infection was associated with gross splenomegaly, microscopic inflammatory lesions in the lung and liver, hyperplastic lesions on the spleen, and clinical pathology abnormalities including neutropenia and monocytosis. This study emphasizes the use of well-defined animal models as a valuable tool for the study of A phagocytophilum infections.
引用
收藏
页码:64 / 73
页数:10
相关论文
共 48 条
[1]
Gamma interferon dominates the murine cytokine response to the agent of human granulocytic ehrlichiosis and helps to control the degree of early rickettsemia [J].
Akkoyunlu, M ;
Fikrig, E .
INFECTION AND IMMUNITY, 2000, 68 (04) :1827-1833
[2]
Antigenic diversity of granulocytic Ehrlichia isolates from humans in Wisconsin and New York and a horse in California [J].
Asanovich, KM ;
Bakken, JS ;
Madigan, JE ;
AgueroRosenfeld, M ;
Wormser, GP ;
Dumler, JS .
JOURNAL OF INFECTIOUS DISEASES, 1997, 176 (04) :1029-1034
[3]
Human granulocytic ehrlichiosis [J].
Bakken, JS ;
Dumler, JS .
CLINICAL INFECTIOUS DISEASES, 2000, 31 (02) :554-560
[4]
HUMAN GRANULOCYTIC EHRLICHIOSIS IN THE UPPER MIDWEST UNITED-STATES - A NEW SPECIES EMERGING [J].
BAKKEN, JS ;
DUMLER, JS ;
CHEN, SM ;
ECKMAN, MR ;
VANETTA, LL ;
WALKER, DH .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1994, 272 (03) :212-218
[5]
Bjoersdorff A., 1990, Svensk Veterinartidning, V42, P357
[6]
Human granulocytic ehrlichiosis in Europe [J].
Blanco, JR ;
Oteo, JA .
CLINICAL MICROBIOLOGY AND INFECTION, 2002, 8 (12) :763-772
[7]
Roles of noutrophil β2 integrins in kinetics of bacteremia, extravasation, and tick acquisition of Anaplasma phagocytophila in mice [J].
Borjesson, DL ;
Simon, SI ;
Hodzic, E ;
DeCock, HEV ;
Ballantyne, CM ;
Barthold, SW .
BLOOD, 2003, 101 (08) :3257-3264
[8]
Kinetics of CD11b/CD18 up-regulation during infection with the agent of human granulocytic ehrlichiosis in mice [J].
Borjesson, DL ;
Simon, SI ;
Hodzic, E ;
Ballantyne, CM ;
Barthold, SW .
LABORATORY INVESTIGATION, 2002, 82 (03) :303-311
[9]
Borjesson DL, 2002, COMPARATIVE MED, V52, P403
[10]
Thrombocytopenia in a mouse model of human granulocytic ehrlichiosis [J].
Borjesson, DL ;
Simon, SI ;
Tablin, F ;
Barthold, SW .
JOURNAL OF INFECTIOUS DISEASES, 2001, 184 (11) :1475-1479